Christie + Co
Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation Links
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.
 

Posted on: 26/09/2011

Latest news stories

27/09/2016
Outsourcing company Mitie has issued a profit warning ahead of its results for the second half of 2015-16 and claims its healthcare division is partly to blame.
26/09/2016
Hip and knee replacements carried out by the independent sector contribute £540-£692 million towards the UK economy every year, according to a new report.
26/09/2016
Healthcare packaging supplier Laminar Medica has been acquired by New York-listed Sonoco ThermoSafe, a subsidiary of Sonoco.
23/09/2016
The College of Haringey, Enfield & North East London has won a contract with Whittington Health NHS Trust to train apprentices.
23/09/2016
AIM-listed Constellation Healthcare Technologies has acquired US revenue cycle management firm Vega Medical Professionals.






The fostering market has drivers that are highly attractive to investors but achieving scale is not as easy as it looks, finds Ploy Radford
Read more...


Christie + Co

The failed Cambridgeshire elderly people’s contract, which saw Uniting Care throwing in the towel after just eight months, has made headlines everywhere. But what exactly went wrong, asks Luke Cloherty
Read more...


Tim Ashlin is partner at private equity house Synova Capital
Lumeon (formerly Qinec) is looking to change the way care pathways are managed, shared and monetised. Its chief operating officer Andrew Wyatt tells HealthInvestor about its new platform, Marketplace
Ardian and GHO Capital have acquired Envision Pharma from Halifax Group. HealthInvestor investigates what drew the companies towards each other
Sir Martin Narey has recommended the ‘Stay close’ agenda in his recent report on children’s care. Clare Connell and Charlotte Bushnell of Connell Consulting explores what this means for the sector
Patrick Bansch and Dr Michelle Tempest of Candesic review the health and wellness market and consider an exciting new investment opportunity in a luxury holistic health hotel

Click here to search all feature articles